SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-060235
Filing Date
2023-11-07
Accepted
2023-11-07 16:07:19
Documents
14
Period of Report
2023-11-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tyra-20231107.htm   iXBRL 8-K 47743
2 EX-99.1 tyra-ex99_1.htm EX-99.1 152778
3 GRAPHIC img74818929_0.jpg GRAPHIC 2226
  Complete submission text file 0000950170-23-060235.txt   330639

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tyra-20231107_lab.xml EX-101.LAB 13350
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tyra-20231107_pre.xml EX-101.PRE 9824
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tyra-20231107.xsd EX-101.SCH 2445
8 EXTRACTED XBRL INSTANCE DOCUMENT tyra-20231107_htm.xml XML 4701
Mailing Address 2656 STATE STREET CARLSBAD CA 92008
Business Address 2656 STATE STREET CARLSBAD CA 92008 (619) 728-4760
Tyra Biosciences, Inc. (Filer) CIK: 0001863127 (see all company filings)

IRS No.: 831476348 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40800 | Film No.: 231383716
SIC: 2834 Pharmaceutical Preparations